Vanderbilt Lung Institute — Nashville, Tennessee

Vanderbilt Lung Institute is a clinical research site located in Nashville, Tennessee, United States 37204.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Vanderbilt Lung Institute has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Progressive Pulmonary Fibrosis.

Sponsors: Avalyn Pharma Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Vanderbilt Lung Institute?

Vanderbilt Lung Institute has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Vanderbilt Lung Institute conducted?

Vanderbilt Lung Institute has 1 clinical trials on record, with 1 currently active. Their work covers Progressive Pulmonary Fibrosis.

Is Vanderbilt Lung Institute accredited by Crixeo Health?

Vanderbilt Lung Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Vanderbilt Lung Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.